fda approves first oral glp-1 obesity drug august 21 2025 Orforglipron, approved as Foundayo on April 1, 2026, adds another option for chronic weight management in adults with or overweight plus at least one weight-related condition. The clinical relevance New oral GLP-1 drugs could
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 20 - Nov 25




:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)





















